Trial Profile
Pharmacokinetics of single ascending doses of tariquidar in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Aug 2013
Price :
$35
*
At a glance
- Drugs Tariquidar (Primary)
- Indications Breast cancer; Non-small cell lung cancer
- Focus Pharmacokinetics
- 14 Aug 2013 New trial record